Clinical Trials Browser

Hepatitis B Reactivation × tenofovir alafenamide × Clear all

NCT04619082 2024-11-12

TAF to Prevent HBV Reactivation in Cancer Patients

Phase 4 Active not recruiting

Hepatitis B Reactivation